🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Patients with a high grade glioma have an increasing overall survival and p...
Status
Withdrawn
Location
Maastricht Radiation Oncology
Start Date
2013-03
Trial ID
NCT01711580
Lung cancer is the leading cause of cancer death in the United States. Curr...
Status
Completed
Location
University of Minnesota
Start Date
2005-09
Trial ID
NCT00218179
Treatments Being Tested
This pilot study is the first step in the development of an new assay that ...
Status
Completed
Location
BC Cancer Agency
Start Date
2016-02
Trial ID
NCT02622776
Treatments Being Tested
This is a combined prospective and retrospective observational study aiming...
Status
Recruiting
Location
Department of Pharmacology, Yonsei University College of Medicine
Start Date
2024-08-21
Trial ID
NCT07035587
Treatments Being Tested
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-25
Trial ID
NCT05554328
This partially randomized phase I/II trial studies the side effects and the...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2010-04-14
Trial ID
NCT01116648
This phase I trial tests the safety, side effects, best dose of MUC1-activa...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2024-09-20
Trial ID
NCT06483048
This phase III trial studies olaparib or cediranib maleate and olaparib to ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2016-03-28
Trial ID
NCT02446600
Treatments Being Tested
Ovarian cancer is the most lethal gynaecological malignancy, but its incide...
Status
Recruiting
Location
Shanghai first maternity and infant hospital
Start Date
2013-01-01
Trial ID
NCT06118307
This phase II trial tests how well darolutamide in combination with leuprol...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2024-02-08
Trial ID
NCT06169124